Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0001179110-20-012059

VP, Clinical&Translational Sc gave up 4,373 shares (to pay taxes)

  • VP, Clinical&Translational Sc acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-15 Option exercise +15,000 $4.81 $72,150 66,056 D
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-15 Shares withheld for taxes −4,373 $16.50 $72,155 61,683 D
Derivatives
DeVinney Erick Wayne VP, Clinical&Translational Sc 2020-12-15 Option exercise · Employee Stock Option (right to buy) −15,000 0 D
Loading xslF345X03/edgar.xml…